Vaping-associated acute respiratory distress syndrome managed with VV-ECMO: a case report
Abstract
Abstract Electronic cigarettes (e-cigarettes) have been increasingly promoted as safer alternatives to conventional smoking and as smoking cessation tools. However, emerging evidence has linked e-cigarette use to serious pulmonary complications, including e-cigarette or vaping product associated lung injury (EVALI). Severe cases may progress to acute respiratory distress syndrome (ARDS), requiring advanced respiratory support. We report the case of a previously healthy 25-year-old female who developed severe vaping-associated ARDS refractory to conventional mechanical ventilation and was successfully managed with veno-venous extracorporeal membrane oxygenation (VV-ECMO). This case highlights the potential severity of vaping-related lung injury and emphasizes the role of ECMO as a life-saving intervention in selected patients.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.